New

Anal Cancer Market

2021

Anal Cancer Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Carcinoma in Situ, Squamous Cell Carcinoma, Adenocarcinoma, Basal Cell Carcinoma, Melanoma, Others); Treatment Type (Chemotherapy, Surgery, Radiation Therapy, Immunotherapy); End User (Hospitals and Clinics, Research and Academic Institutes, Ambulatory Surgical Centers, Others) and Geography

| Report Code: TIPRE00017614 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Market Insights

Anal Cancer Market 2028 By Type, Treatment Type, End User and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Anal cancer is a rare type of malignancy that starts in the anus, which is the rectum's end. This type of cancer is usually associated with human papillomavirus (HPV), a sexually transmitted infection. It's prevalent in a majority of anal cancer cases. Some symptoms can might show bleeding from the anal area, lump or swelling near the anus or change in bowel habits, etc.

MARKET DYNAMICS

Factors such as the growing number of sexually transmitted diseases and rising prevalence of anal cancer are expected to drive market growth. Moreover, increasing research and development expenditure in oncology is also likely to boost the market growth. The high cost of anal cancer treatment and low awareness of this cancer act as major restraints for the market growth.

MARKET SCOPE

The "Anal Cancer Market Analysis to 2028" is a specialized and in-depth study of the Biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of anal cancer market with detailed market segmentation with type, treatment type and end user. The anal cancer market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in anal cancer market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The anal cancer market is segmented on the basis of type, treatment type and end user. On the basis of type, the anal cancer market is divided into carcinoma in situ, squamous cell carcinoma, adenocarcinoma, basal cell carcinoma, melanoma and others. On basis of treatment type, market can be segmented into chemotherapy, surgery, radiation therapy and immunotherapy. Based on end user, the anal cancer market can be segmented as hospitals and clinics, research and academic institutes, ambulatory surgical centres and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the anal cancer market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The anal cancer market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyses factors affecting anal cancer market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the anal cancer market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in anal cancer market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from anal cancer market are anticipated to have lucrative growth opportunities in the future with the rising demand for anal cancer in the global market. Below mentioned is the list of few companies engaged in the anal cancer market.

The report also includes the profiles of key players in anal cancer market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •  Advaxis, Inc.
  •  ORYX GmbH and Co. KG
  •  Eli Lilly and Company
  •  Genticel S.A
  •  Merck and Co., Inc.
  •  F. Hoffmann-La Roche Ltd
  •  GlaxoSmithKline plc
  •  Onconova Therapeutics Inc.
  •  BioMimetix JV, LLC
  •  Bayer AG

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Anal Cancer Market - By Type
1.3.2 Anal Cancer Market - By Treatment Type
1.3.3 Anal Cancer Market - By End User
1.3.4 Anal Cancer Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. ANAL CANCER MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ANAL CANCER MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. ANAL CANCER MARKET - GLOBAL MARKET ANALYSIS
6.1. ANAL CANCER - GLOBAL MARKET OVERVIEW
6.2. ANAL CANCER - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. ANAL CANCER MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. CARCINOMA IN SITU
7.3.1. Overview
7.3.2. Carcinoma in Situ Market Forecast and Analysis
7.4. SQUAMOUS CELL CARCINOMA
7.4.1. Overview
7.4.2. Squamous Cell Carcinoma Market Forecast and Analysis
7.5. ADENOCARCINOMA
7.5.1. Overview
7.5.2. Adenocarcinoma Market Forecast and Analysis
7.6. BASAL CELL CARCINOMA
7.6.1. Overview
7.6.2. Basal Cell Carcinoma Market Forecast and Analysis
7.7. MELANOMA
7.7.1. Overview
7.7.2. Melanoma Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. ANAL CANCER MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT TYPE
8.1. OVERVIEW
8.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
8.3. CHEMOTHERAPY
8.3.1. Overview
8.3.2. Chemotherapy Market Forecast and Analysis
8.4. SURGERY
8.4.1. Overview
8.4.2. Surgery Market Forecast and Analysis
8.5. RADIATION THERAPY
8.5.1. Overview
8.5.2. Radiation Therapy Market Forecast and Analysis
8.6. IMMUNOTHERAPY
8.6.1. Overview
8.6.2. Immunotherapy Market Forecast and Analysis
9. ANAL CANCER MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS AND CLINICS
9.3.1. Overview
9.3.2. Hospitals and Clinics Market Forecast and Analysis
9.4. RESEARCH AND ACADEMIC INSTITUTES
9.4.1. Overview
9.4.2. Research and Academic Institutes Market Forecast and Analysis
9.5. AMBULATORY SURGICAL CENTERS
9.5.1. Overview
9.5.2. Ambulatory Surgical Centers Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis

10. ANAL CANCER MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Anal Cancer Market Overview
10.1.2 North America Anal Cancer Market Forecasts and Analysis
10.1.3 North America Anal Cancer Market Forecasts and Analysis - By Type
10.1.4 North America Anal Cancer Market Forecasts and Analysis - By Treatment Type
10.1.5 North America Anal Cancer Market Forecasts and Analysis - By End User
10.1.6 North America Anal Cancer Market Forecasts and Analysis - By Countries
10.1.6.1 United States Anal Cancer Market
10.1.6.1.1 United States Anal Cancer Market by Type
10.1.6.1.2 United States Anal Cancer Market by Treatment Type
10.1.6.1.3 United States Anal Cancer Market by End User
10.1.6.2 Canada Anal Cancer Market
10.1.6.2.1 Canada Anal Cancer Market by Type
10.1.6.2.2 Canada Anal Cancer Market by Treatment Type
10.1.6.2.3 Canada Anal Cancer Market by End User
10.1.6.3 Mexico Anal Cancer Market
10.1.6.3.1 Mexico Anal Cancer Market by Type
10.1.6.3.2 Mexico Anal Cancer Market by Treatment Type
10.1.6.3.3 Mexico Anal Cancer Market by End User
10.2. EUROPE
10.2.1 Europe Anal Cancer Market Overview
10.2.2 Europe Anal Cancer Market Forecasts and Analysis
10.2.3 Europe Anal Cancer Market Forecasts and Analysis - By Type
10.2.4 Europe Anal Cancer Market Forecasts and Analysis - By Treatment Type
10.2.5 Europe Anal Cancer Market Forecasts and Analysis - By End User
10.2.6 Europe Anal Cancer Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Anal Cancer Market
10.2.6.1.1 Germany Anal Cancer Market by Type
10.2.6.1.2 Germany Anal Cancer Market by Treatment Type
10.2.6.1.3 Germany Anal Cancer Market by End User
10.2.6.2 France Anal Cancer Market
10.2.6.2.1 France Anal Cancer Market by Type
10.2.6.2.2 France Anal Cancer Market by Treatment Type
10.2.6.2.3 France Anal Cancer Market by End User
10.2.6.3 Italy Anal Cancer Market
10.2.6.3.1 Italy Anal Cancer Market by Type
10.2.6.3.2 Italy Anal Cancer Market by Treatment Type
10.2.6.3.3 Italy Anal Cancer Market by End User
10.2.6.4 Spain Anal Cancer Market
10.2.6.4.1 Spain Anal Cancer Market by Type
10.2.6.4.2 Spain Anal Cancer Market by Treatment Type
10.2.6.4.3 Spain Anal Cancer Market by End User
10.2.6.5 United Kingdom Anal Cancer Market
10.2.6.5.1 United Kingdom Anal Cancer Market by Type
10.2.6.5.2 United Kingdom Anal Cancer Market by Treatment Type
10.2.6.5.3 United Kingdom Anal Cancer Market by End User
10.2.6.6 Rest of Europe Anal Cancer Market
10.2.6.6.1 Rest of Europe Anal Cancer Market by Type
10.2.6.6.2 Rest of Europe Anal Cancer Market by Treatment Type
10.2.6.6.3 Rest of Europe Anal Cancer Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Anal Cancer Market Overview
10.3.2 Asia-Pacific Anal Cancer Market Forecasts and Analysis
10.3.3 Asia-Pacific Anal Cancer Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Anal Cancer Market Forecasts and Analysis - By Treatment Type
10.3.5 Asia-Pacific Anal Cancer Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Anal Cancer Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Anal Cancer Market
10.3.6.1.1 Australia Anal Cancer Market by Type
10.3.6.1.2 Australia Anal Cancer Market by Treatment Type
10.3.6.1.3 Australia Anal Cancer Market by End User
10.3.6.2 China Anal Cancer Market
10.3.6.2.1 China Anal Cancer Market by Type
10.3.6.2.2 China Anal Cancer Market by Treatment Type
10.3.6.2.3 China Anal Cancer Market by End User
10.3.6.3 India Anal Cancer Market
10.3.6.3.1 India Anal Cancer Market by Type
10.3.6.3.2 India Anal Cancer Market by Treatment Type
10.3.6.3.3 India Anal Cancer Market by End User
10.3.6.4 Japan Anal Cancer Market
10.3.6.4.1 Japan Anal Cancer Market by Type
10.3.6.4.2 Japan Anal Cancer Market by Treatment Type
10.3.6.4.3 Japan Anal Cancer Market by End User
10.3.6.5 South Korea Anal Cancer Market
10.3.6.5.1 South Korea Anal Cancer Market by Type
10.3.6.5.2 South Korea Anal Cancer Market by Treatment Type
10.3.6.5.3 South Korea Anal Cancer Market by End User
10.3.6.6 Rest of Asia-Pacific Anal Cancer Market
10.3.6.6.1 Rest of Asia-Pacific Anal Cancer Market by Type
10.3.6.6.2 Rest of Asia-Pacific Anal Cancer Market by Treatment Type
10.3.6.6.3 Rest of Asia-Pacific Anal Cancer Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Anal Cancer Market Overview
10.4.2 Middle East and Africa Anal Cancer Market Forecasts and Analysis
10.4.3 Middle East and Africa Anal Cancer Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Anal Cancer Market Forecasts and Analysis - By Treatment Type
10.4.5 Middle East and Africa Anal Cancer Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Anal Cancer Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Anal Cancer Market
10.4.6.1.1 South Africa Anal Cancer Market by Type
10.4.6.1.2 South Africa Anal Cancer Market by Treatment Type
10.4.6.1.3 South Africa Anal Cancer Market by End User
10.4.6.2 Saudi Arabia Anal Cancer Market
10.4.6.2.1 Saudi Arabia Anal Cancer Market by Type
10.4.6.2.2 Saudi Arabia Anal Cancer Market by Treatment Type
10.4.6.2.3 Saudi Arabia Anal Cancer Market by End User
10.4.6.3 U.A.E Anal Cancer Market
10.4.6.3.1 U.A.E Anal Cancer Market by Type
10.4.6.3.2 U.A.E Anal Cancer Market by Treatment Type
10.4.6.3.3 U.A.E Anal Cancer Market by End User
10.4.6.4 Rest of Middle East and Africa Anal Cancer Market
10.4.6.4.1 Rest of Middle East and Africa Anal Cancer Market by Type
10.4.6.4.2 Rest of Middle East and Africa Anal Cancer Market by Treatment Type
10.4.6.4.3 Rest of Middle East and Africa Anal Cancer Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Anal Cancer Market Overview
10.5.2 South and Central America Anal Cancer Market Forecasts and Analysis
10.5.3 South and Central America Anal Cancer Market Forecasts and Analysis - By Type
10.5.4 South and Central America Anal Cancer Market Forecasts and Analysis - By Treatment Type
10.5.5 South and Central America Anal Cancer Market Forecasts and Analysis - By End User
10.5.6 South and Central America Anal Cancer Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Anal Cancer Market
10.5.6.1.1 Brazil Anal Cancer Market by Type
10.5.6.1.2 Brazil Anal Cancer Market by Treatment Type
10.5.6.1.3 Brazil Anal Cancer Market by End User
10.5.6.2 Argentina Anal Cancer Market
10.5.6.2.1 Argentina Anal Cancer Market by Type
10.5.6.2.2 Argentina Anal Cancer Market by Treatment Type
10.5.6.2.3 Argentina Anal Cancer Market by End User
10.5.6.3 Rest of South and Central America Anal Cancer Market
10.5.6.3.1 Rest of South and Central America Anal Cancer Market by Type
10.5.6.3.2 Rest of South and Central America Anal Cancer Market by Treatment Type
10.5.6.3.3 Rest of South and Central America Anal Cancer Market by End User

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. ANAL CANCER MARKET, KEY COMPANY PROFILES
12.1. ADVAXIS, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ORYX GMBH AND CO. KG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ELI LILLY AND COMPANY
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. GENTICEL S.A
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MERCK AND CO., INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. F. HOFFMANN-LA ROCHE LTD
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GLAXOSMITHKLINE PLC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ONCONOVA THERAPEUTICS INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. BIOMIMETIXJV, LLC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BAYER AG
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
  • Advaxis, Inc.
  • ORYX GmbH and Co. KG
  • Eli Lilly and Company
  • Genticel S.A
  • Merck and Co., Inc.
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc
  • Onconova Therapeutics Inc.
  • BioMimetix JV, LLC
  • Bayer AG
TIPRE00017614
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.